Literature DB >> 26228747

NCI-MATCH trial pushes cancer umbrella trial paradigm.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26228747     DOI： 10.1038/nrd4694

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  34 in total

1.  Targeted therapy according to next generation sequencing-based panel sequencing.

Authors:  Motonobu Saito; Tomoyuki Momma; Koji Kono
Journal:  Fukushima J Med Sci       Date:  2018-04-07

2.  Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Authors:  Chih-Jian Lih; Robin D Harrington; David J Sims; Kneshay N Harper; Courtney H Bouk; Vivekananda Datta; Jonathan Yau; Rajesh R Singh; Mark J Routbort; Rajyalakshmi Luthra; Keyur P Patel; Geeta S Mantha; Savitri Krishnamurthy; Karyn Ronski; Zenta Walther; Karin E Finberg; Sandra Canosa; Hayley Robinson; Amelia Raymond; Long P Le; Lisa M McShane; Eric C Polley; Barbara A Conley; James H Doroshow; A John Iafrate; Jeffrey L Sklar; Stanley R Hamilton; P Mickey Williams
Journal:  J Mol Diagn       Date:  2017-02-07       Impact factor: 5.568

Review 3.  Update on Gastroesophageal Adenocarcinoma Targeted Therapies.

Authors:  Steven B Maron; Daniel V T Catenacci
Journal:  Hematol Oncol Clin North Am       Date:  2017-06       Impact factor: 3.722

Review 4.  Novel Targeted Therapies for Esophagogastric Cancer.

Authors:  Steven B Maron; Daniel V T Catenacci
Journal:  Surg Oncol Clin N Am       Date:  2017-04       Impact factor: 3.495

5.  Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy.

Authors:  Benjamin Chin-Yee; S V Subramanian; Amol A Verma; Andreas Laupacis; Fahad Razak
Journal:  Milbank Q       Date:  2018-06       Impact factor: 4.911

6.  A subgroup cluster-based Bayesian adaptive design for precision medicine.

Authors:  Wentian Guo; Yuan Ji; Daniel V T Catenacci
Journal:  Biometrics       Date:  2016-10-24       Impact factor: 2.571

Review 7.  Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.

Authors:  L A Renfro; D J Sargent
Journal:  Ann Oncol       Date:  2017-01-01       Impact factor: 32.976

Review 8.  Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Authors:  Keith T Schmidt; Cindy H Chau; Douglas K Price; William D Figg
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126

9.  Identification of an "Exceptional Responder" Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy.

Authors:  Hugh S Gannon; Nathan Kaplan; Aviad Tsherniak; Francisca Vazquez; Barbara A Weir; William C Hahn; Matthew Meyerson
Journal:  Mol Cancer Res       Date:  2015-11-18       Impact factor: 5.852

10.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.